NCT06769698
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06769698
Title A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Oncology Hematology West P.C. dba Nebraska Cancer Specialists RECRUITING Omaha Nebraska 68130 United States Details
Joe Arrington Cancer Research & Treatment Center RECRUITING Lubbock Texas 79410 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field